BR0015578A - Arilóxi propanolaminas para melhorar a produção de rebanhos - Google Patents

Arilóxi propanolaminas para melhorar a produção de rebanhos

Info

Publication number
BR0015578A
BR0015578A BR0015578-0A BR0015578A BR0015578A BR 0015578 A BR0015578 A BR 0015578A BR 0015578 A BR0015578 A BR 0015578A BR 0015578 A BR0015578 A BR 0015578A
Authority
BR
Brazil
Prior art keywords
structural formula
independently
ring
production
straight
Prior art date
Application number
BR0015578-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Randall Bruce Hopkins
Deana Lori Hancock
Michael Eugene Quimby
Roger Ryan Rothhaar
John Arnold Werner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR0015578A publication Critical patent/BR0015578A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BR0015578-0A 1999-11-15 2000-11-13 Arilóxi propanolaminas para melhorar a produção de rebanhos BR0015578A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16546099P 1999-11-15 1999-11-15
PCT/US2000/031060 WO2001036413A1 (en) 1999-11-15 2000-11-13 Aryloxy propanolamines for improving livestock production

Publications (1)

Publication Number Publication Date
BR0015578A true BR0015578A (pt) 2002-07-09

Family

ID=22598982

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015578-0A BR0015578A (pt) 1999-11-15 2000-11-13 Arilóxi propanolaminas para melhorar a produção de rebanhos

Country Status (16)

Country Link
JP (1) JP2003514815A (zh)
KR (1) KR20020059730A (zh)
CN (1) CN1390213A (zh)
AU (1) AU1917401A (zh)
BR (1) BR0015578A (zh)
CA (1) CA2391654A1 (zh)
CO (1) CO5221077A1 (zh)
CZ (1) CZ20021644A3 (zh)
EA (1) EA200200569A1 (zh)
IL (1) IL149570A0 (zh)
MX (1) MXPA02004653A (zh)
NO (1) NO20022290L (zh)
PE (1) PE20010707A1 (zh)
PL (1) PL355669A1 (zh)
SV (1) SV2002000216A (zh)
WO (1) WO2001036413A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103325D0 (sv) 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
EP1778638A1 (en) 2004-07-21 2007-05-02 Theravance, Inc. Diaryl ether beta2 adrenergic receptor agonists
US20130224320A1 (en) * 2012-02-23 2013-08-29 Joan Torrent Campmany Process to improve feed efficiency and carcass characteristics of animals
CN111925329B (zh) * 2020-09-14 2021-01-12 正大预混料（天津）有限公司 一种芪三酚衍生物及其组合物、制备方法和用途
CN115611752A (zh) * 2022-10-21 2023-01-17 江苏天和制药有限公司 一种卢巴贝隆中间体的合成精制方法
CN117296990B (zh) * 2023-08-08 2024-02-23 河南蒜宝生物科技有限公司 一种安全绿色含大蒜提取物的复合饲料添加剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
EP0827746B1 (en) * 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores

Also Published As

Publication number Publication date
NO20022290D0 (no) 2002-05-14
PL355669A1 (en) 2004-05-04
AU1917401A (en) 2001-05-30
SV2002000216A (es) 2002-07-16
CA2391654A1 (en) 2001-05-25
KR20020059730A (ko) 2002-07-13
WO2001036413A1 (en) 2001-05-25
JP2003514815A (ja) 2003-04-22
CN1390213A (zh) 2003-01-08
CZ20021644A3 (cs) 2002-10-16
IL149570A0 (en) 2002-11-10
MXPA02004653A (es) 2002-09-02
NO20022290L (no) 2002-07-09
EA200200569A1 (ru) 2003-06-26
CO5221077A1 (es) 2002-11-28
PE20010707A1 (es) 2001-07-11

Similar Documents

Publication Publication Date Title
EA200100486A1 (ru) Производные 2-уреидотиазола, способ их получения и применение указанных веществ в качестве противоопухолевых средств
BR0010476A (pt) Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais
EA199901015A1 (ru) 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
BR0014139A (pt) Derivado de diamida aromática ou um seu sal, composição agrìcola e hortìcola, e, método para utilizar uma composição agrìcola e hortìcola
BR9810021A (pt) Derivados 9-oxima-eritromicina
BRPI0512526A (pt) composto, composição farmacêutica, método para tratar um paciente com cáncer e método para preparar um di-sal de bis(tio-hidrazida amida)
CY1107080T1 (el) Υποκατεστημενες ινδολο-βασεις του mannich
RU94030812A (ru) Производные фосфоноянтарной кислоты, способ их получения и содержащие эти соединения фармацевтические композиции
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
DK616388D0 (da) Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning
BR0015578A (pt) Arilóxi propanolaminas para melhorar a produção de rebanhos
DE69006072D1 (de) Verfahren zur Herstellung von N-Methyl-3-(p-Trifluoromethyl-phenoxy)-3-phenyl-propylamin und ihre Salze.
GB1360461A (en) Isoflavone derivative
DK630987D0 (da) Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
NO941451D0 (no) Oksazolinderivat
DK0493883T3 (da) Cykliske (hetero)acetaler af nitrosubstituerede benzaldehyder med anticanceraktivitet
EA200101100A1 (ru) Новые ароматические амиды, замещенные рибозой, способ их получения и их применение в качестве лекарств
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
TNSN97092A1 (ar) مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
AR033685A1 (es) Derivados del acido tetramico, coniosetina y derivados de la misma, procedimiento para su preparacion, medicamentos, procedimiento para la preparacion de medicamentos, empleo de dichos derivados para la preparacion de medicamentos
EA199800464A1 (ru) Синергическая иммуносупрессорная композиция, содержащая 2,2'-би-1н-пиррольное соединение
BRPI0414580A (pt) derivado do ácido fenilacético, processos para sua produção e uso
AR024671A1 (es) Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos
KR890002168A (ko) 디하이드로-1,4-옥사지노[2,3-c]퀴놀린, 그의 제조방법 및 중간생성물 및 약제로서의 용도

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]